Interactive role of breast cancer on dyslipidemia and hypertension metabolic risk according to treatment exposure and menopausal status

[1] Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2009; 59: 225–249. JemalA SiegelR WardE HaoY XuJ ThunMJ Cancer statistics CA Cancer J Clin 2009 59 225 249 10.3322/caac.2000619474385 Search in Google Scholar

[2] Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in. Summary and conclusions. Br J Cancer. 2011; 105, 77–81. ParkinDM BoydL WalkerLC The fraction of cancer attributable to lifestyle and environmental factors in the UK in. Summary and conclusions Br J Cancer 2011 105 77 81 10.1038/bjc.2011.489325206522158327 Search in Google Scholar

[3] Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J ClinNutr. 2007; 86(3): s823–s835. XueF MichelsKB Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am J ClinNutr 2007 86 3 s823 s835 10.1093/ajcn/86.3.823S18265476 Search in Google Scholar

[4] Bahl M., Ennis M, Tannock IF, Hux JE, Pritchard, KI, Koo J et al. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat. 2005; 94:135–144. BahlM EnnisM TannockIF HuxJE PritchardKI KooJ Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study Breast Cancer Res Treat 2005 94 135 144 10.1007/s10549-005-6654-916261412 Search in Google Scholar

[5] Franky DS, Shilin NS, Pankaj MS, Patel HR, Prabhudas SP. Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther. 2008; 7: 33–41. FrankyDS ShilinNS PankajMS PatelHR PrabhudasSP Significance of alterations in plasma lipid profile levels in breast cancer Integr Cancer Ther. 2008 7 33 41 10.1177/153473540731388318292593 Search in Google Scholar

[6] Shah FD, Shukla SN, Shah PM, Patel RH, Patel PS. Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer. Integrative Cancer Therapies. 2008; 7(1): 33–41. ShahFD ShuklaSN ShahPM PatelRH PatelPS Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer Integrative Cancer Therapies 2008 7 1 33 41 10.1177/1534735407313883 Search in Google Scholar

[7] Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009; 124:1213–1219. BraithwaiteD TammemagiCM MooreDH OzanneEM HiattRA BelkoraJ Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients Int J Cancer 2009 124 1213 1219 10.1002/ijc.2405419058216 Search in Google Scholar

[8] Hammoudeh A, Al-Tarawneh H, Elharassis A, Haddad J, Mahadeen Z, Badran N, et al. Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan hyperlipidemia and related targets study (JoHARTS). INT J CARDIOL. 2006; 110: 179–183. HammoudehA Al-TarawnehH ElharassisA HaddadJ MahadeenZ BadranN Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan hyperlipidemia and related targets study (JoHARTS) INT J CARDIOL. 2006 110 179 183 10.1016/j.ijcard.2005.08.00516233922 Search in Google Scholar

[9] Khader Y, Batieha A, El-Khateeb M, Al-Omari M, Ajlouni K. Prevalence of dyslipidemia and its associated factors among Jordanian adults. Journal of Clinical Lipidology. 2010; 4: 53–58. KhaderY BatiehaA El-KhateebM Al-OmariM AjlouniK Prevalence of dyslipidemia and its associated factors among Jordanian adults Journal of Clinical Lipidology. 2010 4 53 58 10.1016/j.jacl.2009.12.00421122627 Search in Google Scholar

[10] Al-Odat A, Ahmad MN, Haddad F: References of Anthropometric Indices of Central Obesity and Metabolic Syndrome in Jordanian Men and Women. Diabetes Metab Syndrome: Clin Res Rev 2012; 6: 15–21. Al-OdatA AhmadMN HaddadF References of Anthropometric Indices of Central Obesity and Metabolic Syndrome in Jordanian Men and Women Diabetes Metab Syndrome: Clin Res Rev 2012 6 15 21 10.1016/j.dsx.2012.05.01223014249 Search in Google Scholar

[11] Al-Tarawneh M, Arkoob K, Al-Nsour M, Al-Nemry O, Al-Hajawi B: Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis. EMH J 2009; 16(10):1032–1038. Al-TarawnehM ArkoobK Al-NsourM Al-NemryO Al-HajawiB Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis EMH J 2009 16 10 1032 1038 10.26719/2010.16.10.1032 Search in Google Scholar

[12] Lee RD, Nieman DC. Nutrational Assessement, 5th edn, New Yourk: McGraw-Hill. 2010 LeeRD NiemanDC Nutrational Assessement 5th edn New Yourk McGraw-Hill 2010 Search in Google Scholar

[13] Obesity: Preventing and Managing the Global Epidemic. 2000, World Health Organization, Report of a WHO Consultation (WHO Technical Report Series 894) http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ Obesity: Preventing and Managing the Global Epidemic 2000 World Health Organization, Report of a WHO Consultation (WHO Technical Report Series 894) http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ Search in Google Scholar

[14] Matthews DR. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419. MatthewsDR Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 412 419 10.1007/BF002808833899825 Search in Google Scholar

[15] Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120:1640–1645. AlbertiKG EckelRH GrundySM ZimmetPZ CleemanJI DonatoKA Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.19264419805654 Search in Google Scholar

[16] Agnoli C, Berrino F, Abagnato A, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 2010; 20: 41–48. AgnoliC BerrinoF AbagnatoA MutiP PanicoS CrosignaniP Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study Nutr Metab Cardiovasc Dis 2010 20 41 48 10.1016/j.numecd.2009.02.006281953619361966 Search in Google Scholar

[17] Chahil TJ, Ginsberg HN. Diabetic dyslipidaemia. EndocrinMetab Clinic North Amer. 2006; 35: 491–510. ChahilTJ GinsbergHN Diabetic dyslipidaemia EndocrinMetab Clinic North Amer. 2006 35 491 510 10.1016/j.ecl.2006.06.00216959582 Search in Google Scholar

[18] Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manier J, et al. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev. 2010; 19(7): 1737–1745. BjorgeT LukanovaA JonssonH TretliS UlmerH ManierJ Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project Cancer Epidemiol Biomarkers Prev. 2010 19 7 1737 1745 10.1158/1055-9965.EPI-10-023020615887 Search in Google Scholar

[19] Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profil, and breast cancer risk. J Natl Cancer Inst. 2004; 96: 1152–1160. FurbergAS VeierodMB WilsgaardT BernsteinL ThuneI Serum high-density lipoprotein cholesterol, metabolic profil, and breast cancer risk J Natl Cancer Inst. 2004 96 1152 1160 10.1093/jnci/djh21615292387 Search in Google Scholar

[20] Moorman PG, Hulka BS, Hiatt RA. Association between high density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev. 1998; 7(6): 483–8. MoormanPG HulkaBS HiattRA Association between high density lipoprotein cholesterol and breast cancer varies by menopausal status Cancer Epidemiol Biomarkers Prev. 1998 7 6 483 8 Search in Google Scholar

[21] Alschuler L. Reducing risk of breast cancer by focusing on metabolic parameters. Nat Med J. 2013; 5: 10–14. AlschulerL Reducing risk of breast cancer by focusing on metabolic parameters Nat Med J. 2013 5 10 14 Search in Google Scholar

[22] Aparicio-Gallego G, Afonso-Afonso F, Leon-Mateos L, Firvida-Perez J, Vazquez-Estevez S, Lazaro-Quintela M. Molecular basis of hypertension side effects induced by sunitinib. Anticancer Drugs. 2011; 22(1): 1–8. Aparicio-GallegoG Afonso-AfonsoF Leon-MateosL Firvida-PerezJ Vazquez-EstevezS Lazaro-QuintelaM Molecular basis of hypertension side effects induced by sunitinib Anticancer Drugs 2011 22 1 1 8 10.1097/CAD.0b013e328340380620938340 Search in Google Scholar

[23] Mouhayar E, Salahudeen A. Hypertension in cancer patients. Tex Heart Inst J. 2011; 38(3): 263–5. MouhayarE SalahudeenA Hypertension in cancer patients Tex Heart Inst J 2011 38 3 263 5 Search in Google Scholar

[24] Pereira A, Garmendial ML, Alvarado ME, Albala C. Hypertension and the Risk of Breast Cancer in Chilean Women: a Case-control Study. Asian Pacific Journal of Cancer Prevention. 2012; 13(11): 5829–5834. PereiraA GarmendialML AlvaradoME AlbalaC Hypertension and the Risk of Breast Cancer in Chilean Women: a Case-control Study Asian Pacific Journal of Cancer Prevention 2012 13 11 5829 5834 10.7314/APJCP.2012.13.11.582923317264 Search in Google Scholar

[25] Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol. 2011. Retrieved from http://annonc.oxfordjournals.org/content/early/2011/03/17/annonc.mdr025. RosatoV BosettiC TalaminiR LeviF MontellaM GiacosaA Metabolic syndrome and the risk of breast cancer in postmenopausal women Ann Oncol 2011 Retrieved from http://annonc.oxfordjournals.org/content/early/2011/03/17/annonc.mdr025. 10.1093/annonc/mdr02521415236 Search in Google Scholar

[26] Reeves KW, McLaughlin V, Fredman L, Ensrud K, Cauley JA. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control. 2012; 23(8):1241–1251. ReevesKW McLaughlinV FredmanL EnsrudK CauleyJA Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort Cancer Causes Control 2012 23 8 1241 1251 10.1007/s10552-012-0002-2357686022661101 Search in Google Scholar

[27] Park YM, Kwon HS, Lim SY, Lee JH, Yoon KH, Son HY, et al. Optimal Waist Circumference Cut-off Value Reflecting Insulin Resistance as a Diagnostic Criterion of Metabolic Syndrome in a Nondiabetic Korean Population Aged 40 Years and Over: The Chungju Metabolic Disease Cohort (CMC) Study. Yonsei Med J. 2010;51(4):511–518. ParkYM KwonHS LimSY LeeJH YoonKH SonHY Optimal Waist Circumference Cut-off Value Reflecting Insulin Resistance as a Diagnostic Criterion of Metabolic Syndrome in a Nondiabetic Korean Population Aged 40 Years and Over: The Chungju Metabolic Disease Cohort (CMC) Study Yonsei Med J 2010 51 4 511 518 10.3349/ymj.2010.51.4.511288026220499415 Search in Google Scholar

[28] Peeters PH, Van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE. Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypert. 2000; 18: 249–254. PeetersPH Van NoordPA HoesAW FracheboudJ GimbrereCH GrobbeeDE Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer J Hypert. 2000 18 249 254 10.1097/00004872-200018030-0000210726709 Search in Google Scholar

[29] Al-Zeidaneen S, Ahmad M, Al-Ebouse A, Hamad AW: Interactive role of obesity indices on breast cancer severity in Jordanian women. ejbps. 2017; 4(6): 637–644. Al-ZeidaneenS AhmadM Al-EbouseA HamadAW Interactive role of obesity indices on breast cancer severity in Jordanian women ejbps 2017 4 6 637 644 Search in Google Scholar

[30] Al-Zeidaneen S, Ahmad M, Al-Ebouse A. The Impact of Treatment Exposure on Diabetes Biomarkers among Jordanian Breast Cancer Women: A Connection through FBG, C-Peptide and HOMA-IR. Curr Gynecol Oncol. 2017;15 (4), pp. 231–238. DOI: 10.15557/CGO.2017.0022 Al-ZeidaneenS AhmadM Al-EbouseA The Impact of Treatment Exposure on Diabetes Biomarkers among Jordanian Breast Cancer Women: A Connection through FBG, C-Peptide and HOMA-IR Curr Gynecol Oncol 2017 15 4 231 238 10.15557/CGO.2017.0022 Open DOISearch in Google Scholar